BREAKING: Criminal Investigation Launched Into Maker Of Alzheimer’s Drug, Report Says

The U.S. Department of Justice has reportedly launched a criminal investigation into a manufacturer of an Alzheimer’s drug over allegations that the company fabricated research findings for the drug.

Federal prosecutors’ investigation into Cassava Sciences centers around whether the company defrauded investors, government agencies, or consumers, Reuters reported.

The investigation comes after a bombshell report was published last week in Science Magazine about how key images from one of the most cited research papers on Alzheimer’s disease this century might have been intentionally fabricated, throwing off years and hundreds of millions of dollars worth of taxpayer-funded research into the seventh leading cause of death in the United States.

Matthew Schrag, a neuroscientist and physician at Vanderbilt University, stumbled upon the controversial study while investigating an experimental drug for

Continue reading